Sarasota, FL -- (SBWIRE) -- 07/07/2017 -- Zion Market Research has published a new report titled "Urinalysis Market (Consumables, Instruments) for Kidney Diseases, Hypertension, Urinary Tract Infection, Diabetes, Liver Diseases and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021". According to the report, global urinalysis market was valued at around USD 1.35 billion in 2015 and is expected to generate revenue of around USD 1.88 billion by end of 2021, growing at a CAGR of around 6.2% between 2016 and 2021.

Urinalysis is the analysis of urine to diagnose various health disorders. It may be used to screen for and/or help diagnose conditions such as urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Urinalysis helps in detection of abnormalities which might require additional testing and follow-up investigation.

Request Free Sample Research Report @ https://www.zionmarketresearch.com/sample/urinalysis-market

Global urinalysis market is primarily driven by growing incidences of target disease such as kidney disorders, liver problems, diabetes. Other major driving factors for the growth of urinalysis market are growing geriatric population coupled along with the introduction of technologically advanced diagnostics. However, strict government regulations implied on this industry and lack of healthcare infrastructure are major restraints that may curb the growth of the market. Nonetheless, the huge base of the target population and unmet clinical needs in underdeveloped countries is likely to disclose the new avenues for urinalysis market in the near future.

The urinalysis market is segmented on the basis of different products including consumables, instruments. In 2015, consumables segment was the largest segment in urinalysis market and accounted for largest share of the total market. Reagents, dipstick, and disposables are the major consumables used in urinalysis. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/urinalysis-market

Kidney diseases, hypertension, urinary tract infection, diabetes, liver diseases, and others are the key applications segment of the global urinalysis market. The urinary tract infections (UTI) application segment dominated the market in terms of revenue. Urinary tract infections (UTI) application segment hold more than 20% share of urinalysis market. Kidney diseases, hypertension, and diabetes are other major application segments of urinalysis market.

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global urinalysis market. North America is expected to remain the dominant region over the forecast period. Europe was the second largest market for urinalysis in 2015. Asia Pacific is expected to be the fastest growing region in urinalysis market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.

Browse the full report at https://www.zionmarketresearch.com/report/urinalysis-market

Some of the key players in urinalysis market include Mindray, Roche Diagnostics, Siemens Healthcare, Sysmex, ARKRAY Inc., Alere Inc., ACON Laboratories, Inc., Bio-Rad, Labomed, Inc. Teco Diagnostics and Urit Medical., among others.